Alembic Pharmaceuticals share price
You have to be logged in to add this to Watchlist.Alembic Pharmaceuticals is trading 5.29% upper at Rs 1,096.95 as compared to its last closing price. Alembic Pharmaceuticals has been trading in the price range of 1,099.00 & 1,048.00. Alembic Pharmaceuticals has given 37.19% in this year & 2.19% in the last 5 days.
Alembic Pharmaceuticals has TTM P/E ratio 36.66 as compared to the sector P/E of 33.29.There are 9 analysts who have initiated coverage on Alembic Pharmaceuticals. There are 3 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.
The company posted a net profit of 153.40 Crores in its last quarter.
Listed peers of Alembic Pharmaceuticals include Laurus Labs (3.84%), Natco Pharma (0.97%), Alembic Pharmaceuticals (5.29%) etc.
Alembic Pharmaceuticals has a 30.39% public holding.The Mutual Fund holding in Alembic Pharmaceuticals was at 8.90% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in Alembic Pharmaceuticals was at 3.94% in 30 Sep 2024. The FII holding has decreased from the last quarter.
Alembic Pharmaceuticals share price range
|
| ||||
|
| ||||
Alembic Pharmaceuticals share Key Metrics
| Market Cap ( ₹ Cr.) | 20,478.93 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Alembic Pharmaceuticals Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 07-Nov-24 | Quarterly Results |
| 08-Aug-24 | Quarterly Results |
| 09-May-24 | Audited Results & Final Dividend |
| 05-Feb-24 | Quarterly Results |
| 07-Nov-23 | Quarterly Results |
| 04-Aug-23 | Quarterly Results |
| 05-May-23 | Audited Results & Final Dividend |
| 01-Feb-23 | Quarterly Results |
| 11-Nov-22 | Quarterly Results |
| 04-Aug-22 | Quarterly Results & Others |
| Meeting Date | Announcement On | Purpose |
| 22-Jul-24 | 21-Jun-24 | AGM |
| 04-Aug-23 | 05-May-23 | AGM |
| 30-Sep-22 | 02-May-22 | AGM |
| 14-Jun-22 | 10-May-22 | COM |
| 19-Mar-22 | 11-Feb-22 | POM |
| 27-Jul-21 | 15-Jun-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 09-May-24 | 15-Jul-24 | 15-Jul-24 | 11 |
| 05-May-23 | 28-Jul-23 | 28-Jul-23 | 8 |
| 02-May-22 | 18-Aug-22 | 17-Aug-22 | 10 |
| 04-May-21 | - | 19-Jul-21 | 14 |
FAQs about Alembic Pharmaceuticals share price
Alembic Pharmaceuticals is trading at 1096.95 as on Mon Nov 25 2024 09:59:20. This is 5.29% upper as compared to its previous closing price of 1041.80.
The market capitalization of Alembic Pharmaceuticals is 20478.93 Cr as on Mon Nov 25 2024 09:59:20.
The average broker rating on Alembic Pharmaceuticals is Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 0 analysts have given a buy rating
- 5 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Alembic Pharmaceuticals is 1296.15 whereas the 52 wk low is 710.50
Alembic Pharmaceuticals can be analyzed on the following key metrics -
- TTM P/E: 36.66
- Sector P/E: 33.29
- Dividend Yield: 1.06%
- D/E ratio: 0.22
Alembic Pharmaceuticals reported a net profit of 615.82 Cr in 2024.
Alembic Pharmaceuticals Quick Links
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Profit Loss Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks